Clinical Trial Technology Editorial

  1. AI Can't Help Bad ClinOps/Health Equity Data 9/25/2024

    Brian Johnson, Ph.D., VP, R&D Technology at Takeda discusses the huge opportunity of connecting disparate ClinOps data and leveraging generative AI to reduce costs and labor during the clinical process. 

  2. Not What I Expected From A Vendor Conference 9/12/2024

    Dan Schell recounts some of his key takeaways after attending the Veeva R&D Quality Summit in Boston in September 2024. Some of the topics discussed include DCTs, eCOA, and the need to simplify tech integration at sites. 

  3. Why We Need Technology Consolidation In Clinical Trials 8/16/2024

    As more and more trial designs incorporate technologies that generate an immense amount of data, data managers struggle to continuously interconnect disparate systems and standardize data. All of this fuels the need for technology consolidation.

  4. Is Blockchain The Solution To Derisking Unreliable Clinical Trial Data? 8/16/2024

    Technological advances have provided fertile ground for scientific fraud, but blockchain just may be the key to ensuring a transparent, trusted, and certified process for collecting, managing, and analyzing clinical trial data.

  5. Automation: From Protocol Definition To Submission 8/12/2024

    Three members of Merck's global clinical data integration team discuss how automating various parts of the clinical trial process can improve data integrity.

  6. Managing Risk In New And Emerging Trial Technology Trends 7/31/2024

    As technology advances, the risk that comes with integrating them into clinical trials rises. Beazley U.S. Life Sciences Underwriter Brendan Tarte discusses how to manage risk with tech like wearables, DHTs, AI/ML, and more.

  7. Insights Into TMF Challenges & Solutions — Part 2 6/28/2024

    In part 2 of this two-part Q&A, Nicole Palmer, CEO and president of consulting firm Granular Level, gives some good career advice for TMF professionals and talks about TMF audits and the EU’s Clinical Trials Information System (CTIS).

  8. Takeda Chooses Wearable To Improve Patient Experience & Data In Sleep Study 6/27/2024

    Takeda Head of the Orexin Franchise Development and Neuroscience Portfolio Strategy Elena Koundourakis explains why her team decided to pursue the use of DHTs and the benefits of doing so, for both the patients and the data accuracy. 

  9. Insights Into TMF Challenges & Solutions — Part 1 6/26/2024

    This is part one of a two-part Q&A I did with Nicole Palmer about a variety of issues surrounding the trial master file (TMF). In this part, she talks about the TMF Reference Model, moving to an eISF, and challenges with e-signatures. 

  10. The Future Of Epilepsy Research And Transformative Treatments 6/12/2024

    UCB's Head of Epilepsy and Rare Syndromes discusses the future of epilepsy treatment and clinical trials.